Piliguard Pinkeye-1 Trivalent Vaccine for Cattle 50 Doses (100ml)

Piliguard Pinkeye-1 Trivalent Vaccine is a cattle vaccine formulated to aid in the prevention of infectious bovine keratoconjunctivitis (pinkeye) associated with Moraxella bovis strains expressing pili similar to MSD Animal Health strains EPP 63, FLA 64 and SAH 38. This oil-emulsion vaccine is designed for use in healthy cattle before the onset of the pinkeye season to support herd health and productivity.

Who the Product is For

• Veterinarians
• Commercial cattle producers
• Beef cattle operations
• Dairy cattle operations
• Feedlots and breeding herds

Key Benefits

• Assists in the prevention of pinkeye in cattle.
• Targets Moraxella bovis strains associated with infectious bovine keratoconjunctivitis.
• Helps support herd health and minimise production losses associated with pinkeye outbreaks.
• Convenient single-dose vaccination protocol.
• Annual revaccination programme for ongoing protection.

Directions for Use

Use only as directed.

Available Sizes

• 20 mℓ (10 doses)
• 100 mℓ (50 doses)

Storage / Other Instructions

• Store refrigerated between 2°C and 7°C.
• Do not freeze.
• Discard unused vaccine, empty containers and vaccination equipment according to local waste disposal regulations.
• Do not reuse empty containers.

Piliguard Pinkeye-1 Trivalent is intended for use under the guidance of a veterinarian as part of a comprehensive herd health and disease prevention programme. Suitable for veterinary practices, animal health professionals and commercial livestock operations.

• For animal use only.
• Use only as directed.
• Withdrawal period: Do not vaccinate within 60 days prior to slaughter.
• Hypersensitivity reactions may occur following vaccination.
• Temporary reduction in milk production may occur in lactating cattle.
• Localised injection-site reactions or granulomas may occasionally develop.
• Keep out of reach of children, uninformed persons and animals.
• Extreme caution should be exercised when handling oil-emulsion vaccines. Accidental self-injection may cause serious injury and requires immediate medical attention.
• Although this vaccine has been extensively tested under a wide variety of conditions, failure may occur due to factors beyond the manufacturer’s control. If this is suspected, seek veterinary advice and notify